Clinical Trial Update: A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating YM060 for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• YM060

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED